RenovoRx is featured in the February 2013 issue of START-UP, an Elsevier Business Intelligence publication of in-depth profiles of leading-edge companies and technologies, including the most important new trends in the biopharma, medtech and diagnostics industries. Full access to the article is available online on START-UP’s website.
RenovoRx Featured by START-UP
- RenovoRx Announces Sixth U.S. Patent
- RenovoRx Announces Orphan Drug Designation Granted for Treating Bile Duct Cancer
- Parexel Biotech and RenovoRx Reach Key Milestone in Pancreatic Cancer Clinical Trial for Locally-Advanced Pancreatic Cancer
- RenovoRx Announces Issuance of Fifth U.S. Patent
- Contemporary Management of Pancreatic Cancer